|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|
| Assets | ||
| Non-controlled/non-affiliate company investments, at fair value (cost of $797,235) | ||
| Non-controlled/Non-affiliated | ||
| Total non-controlled/non-affiliate company investments, at fair value (cost of $797,235) | ||
| Cash | ||
| Cash equivalents | ||
| Dividend receivable | ||
| Interest receivable | ||
| Receivable for investments sold | ||
| Other assets | ||
| Total assets | ||
| Liabilities | ||
| Secured borrowings (net of $224 deferred financing costs) (See Note 6) | ||
| Interest payable | ||
| Management fees payable | ||
| Distributions payable | ||
| Board of Trustees' fees payable | ||
| Accounts payable and accrued expenses | ||
| Total liabilities | ||
| Net Assets: (See Note 8) | ||
| Common shares of beneficial interest, par value $0.01 per share, unlimited shares authorized, 13,479,560 common shares issued and outstanding | ||
| Paid-in-capital in excess of par value | ||
| Total distributable earnings (loss) | ||
| Total net assets | ||
| Total liabilities and net assets | ||
| Net asset value per share (in dollars per share) |
Loading...
